Telemedicine Is Fastest Growing Segment Fueling The Growth Of The Drug And Gene Delivery Devices Market

https://www.coherentmarketinsights.com/market-insight/drug-and-gene-delivery-devices-market-5864
Drug And Gene Delivery Devices Market



Drug and gene delivery devices are medical devices that are designed to encapsulate drugs or genes and deliver them to targeted sites in the body. These devices offer advantages like improved drug targeting, sustained drug release capabilities and reduced dosing frequency. They are widely used to treat chronic diseases like cancer, diabetes and cardiovascular diseases.


Market Overview:
Drug and gene delivery devices include syringes, pens, pumps and nanoparticle formulations that provide accurate dosing and maintain drug levels within a therapeutic window. These devices help improve patient compliance and offer convenient modes of drug delivery.

Market key trends:
The increasing focus on telemedicine is one of the key trends in the drug and gene delivery devices market. Telemedicine allows remote monitoring of patients, facilitates consultation with healthcare providers via digital means and enables home-based care. This removes the need for frequent hospital visits, thereby improving access and convenience of treatment. The COVID-19 pandemic has further accelerated the adoption of telemedicine as social distancing norms restricted in-person consultations. Many companies are launching telemedicine offerings to expand their reach and better engage with patients opting for virtual care.

The global Drug and Gene Delivery Devices Market Size is estimated to be valued at US$ 169.3 Billion in 2023 and is expected to exhibit a CAGR of 11 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global drug and gene delivery devices market is segmented into devices, by route of administration, by end-user, and region. Based on devices, the market is segmented into invasive devices and non-invasive devices. The invasive devices segment is expected to dominate the market owing to the increasing preference of advanced gene therapy and drug delivery methods that require surgical procedures.

Key Takeaways
The global drug and gene delivery devices market is expected to witness high growth, exhibiting a CAGR of 11% over the forecast period, due to increasing prevalence of chronic diseases.

Regional analysis
North America is expected to hold a major share in the global market due to presence of well-established healthcare infrastructure and increasing adoption of advanced drug delivery systems in the region.

Key players
Key players operating in the drug and gene delivery devices market are Pfizer, Inc., Novartis AG, Kite Pharma, Inc., Bluebird bio, Inc., Becton Dickinson and Company, Amgen, Inc., Vericel Corporation, uniQure N.V., Spark Therapeutics, Inc., Renova Therapeutics, Orchard Therapeutics plc, Kolon Tissue Gene, Inc., Human Stem Cell Institute, Dendreon Pharmaceuticals, Helixmith Co., Ltd (ViroMed Co., Ltd), Bausch & Lomb Incorporated, and Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), among others. Read More: https://www.dailyprbulletin.com/growth-of-the-drug-and-gene-delivery-devices-market-trend-and-share-analysis/

Comments

Post a Comment

Popular posts from this blog

Global Fiber Reinforced Concrete Market Opportunity Analysis and Industry Forecast 2028

Image
  Fiber Reinforced Concrete Market A rise in commercial construction activity is anticipated to fuel the market as a result of the economy's improved state. The need for more office and storage space has been driven by the expansion of industries like food and consumer goods, which has had a large positive impact on the construction sector and the demand for paving slabs as long-lasting and attractive flooring. With the majority of the actors involved in the production and manufacture of the raw materials used in the production of paving slabs, product makers have a highly integrated supply chain. The majority of market participants also benefit from a robust direct distribution network that facilitates a seamless flow of products and enables them to build a broader customer base. Having a wide range of customizable products is important while making purchases. The global Fiber Reinforced Concrete Market was valued at US$ 2,330.40 Mn in 2020 and is forecast to reach a value of US$
Read more

Augmented Reality Is Fastest Growing Segment Fueling The Growth Of Air Defense Systems Market

Image
Air Defense Systems Market Market Overview: Air defense systems provides protection against cruise, tactical and strategic ballistic missiles, unmanned aerial vehicles, and aircraft. They consist of radar systems, interceptor missiles, command and control systems and fire control systems. Air defense systems help detect incoming enemy planes, and intercept missiles and other threats before they reach their targets using air-to-air, surface-to-air, and man-portable missiles. Market key trends: One of the major trends in the air defense systems market is the increasing adoption of augmented reality and artificial intelligence. Augmented reality offers 3D digital interfaces to air defense operators and commanders and overlays geographical data and combat intelligence information onto real-world combat scenarios. This enhances situation awareness, minimizes fatigue and improves decision-making. It is increasingly being incorporated into command and control systems, fire control radars and
Read more

The U.S. Sterile Injectables Market Witnessing Tremendous Growth Due to Rising Prevalence of Chronic Disease

Image
U.S. Sterile Injectables Market    Sterile Injectables are compounded medications with sterile components for intravenous administration. They are composed of small molecules, large molecules, and biologics. In 2018, the global sterile injectable market was valued at US$ 357 billion. During the forecast period, the market is expected to grow at a 7.3% CAGR. The market will likely be driven by the growing demand for these medications in developing countries. The U.S. sterile injectables market is expected to expand over the forecast period due to rising product launches are one of the key factors boosting the growth of this market. Many sterile products fail to meet regulatory requirements. Due to the risk involved, a sterile drug product must meet strict standards. Lack of quality assurance in the manufacturing process can result in low-quality medicines. To combat this risk, manufacturers highly trust CMOs to adhere to rigorous quality standards. Manufacturers of sterile injectables a
Read more